Drug Shortage Report for LUPRON DEPOT

Last updated on 2019-12-07 History
Report ID 99564
Drug Identification Number 00884502
Brand name LUPRON DEPOT
Common or Proper name Lupron depot 3.75mg
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) LEUPROLIDE ACETATE
Strength(s) 3.75MG
Dosage form(s) POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Route of administration INTRAMUSCULAR
Packaging size 1 syringe (3.75mg)
ATC code L02AE
ATC description HORMONES AND RELATED AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-11-21
Actual start date 2019-11-21
Estimated end date 2019-12-06
Actual end date 2019-12-06
Shortage status Resolved
Updated date 2019-12-07
Company comments We are pleased to share that this dossier has been resolved as per expected due date and orders are now being processed as per our normal process. Thank you for your continued partnership
Health Canada comments
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-12-07 French Compare
v5 2019-12-06 French Compare
v4 2019-12-06 English Compare
v3 2019-11-23 French Compare
v2 2019-11-23 English Compare
v1 2019-11-22 English Compare